Quarterly report [Sections 13 or 15(d)]

Note 14 - Derivative Liabilities

v3.25.1
Note 14 - Derivative Liabilities
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Derivatives and Fair Value [Text Block]

NOTE 14  DERIVATIVE LIABILITIES

 

A reconciliation of the changes in fair value of derivative liabilities for the three months ended March 31, 2025 is as follows:
 
   

(in thousands)

 
   

Three Months Ended

 
   

March 31, 2025

 

Balance, Beginning of Period

  $ 4,102  

Issuance of Derivative Liability - Conversion Option

    16  

Change in Fair Value of Derivative Liability

    (516 )

Balance, End of Period

  $ 3,602  

 

Derivative liabilities was nil as of March 31, 2024.

 

In connection with the transaction described in "Note 10 – Business Combinations", on May 1, 2024, the Company issued 945,605 shares of Common Stock to the previous stockholders of SAS and 889,725 shares of Common Stock to the shareholders of Coastal, of which 196,507 and 393,013 shares of Common Stock, respectively, shall be transferred on the 12-month anniversary of the transaction. The holders of such Common Stock have the option, but not the obligation, to exchange shares of the Company's Common Stock received as part of the purchase price for a promissory note (the "Put Option"). The Put Option is exercisable 24 months subsequent to the closing date for a period of 90 days thereafter. The Put Option met the criteria in ASC 815-15 and is therefore classified as a derivative liability at fair value with changes being reported through the statement of operations. Refer to "Note 15 – Stockholders' Deficit" for further information on the underlying common shares. The fair value of the Put Option was $3.34 million as of March 31, 2025. The fair value of the Put Option was determined using the Black-Scholes simulation model based on Level 3 inputs on the fair value hierarchy. The following inputs and assumptions were used for the periods presented:

 

   

Issuance Date

   

March 31, 2025

 

Share Price

  $ 0.71     $ 0.93  

Exercise Price

  $ 2.75     $ 2.75  

Expected Life (in Years)

    2.25       1.33  

Annualized Volatility

    88.0 %     95.3 %

Risk-Free Annual Interest Rate

    4.9 %     4.0 %

 

The Unsecured Promissory Note dated November 12, 2024, as amended and restated on December 31, 2024, referred to as the A&R Note, and the Unsecured Promissory Notes dated January 8, 2025  may be automatically converted into shares of Common Stock upon its next bona fide equity financing with proceeds of at least $10.00 million or such lesser amount as approved by the lender, at a conversion price equal to the lesser of (x) 85% of the lowest price paid by the cash investors in such qualifying financing and (y) the price represented by a $30.00 million pre-money valuation of the Company (the "Conversion Option"). The conversion price is unknown at the issuance date and determined by future equity financing. The Conversion Option met the criteria in ASC 815-15 and is therefore classified as a derivative liability at fair value with changes being reported through the statement of operations. The fair value of the Conversion Option was $0.26 million as of  March 31, 2025. The fair value of the Conversion Option was determined using the Monte Carlo simulation model based on Level 3 inputs on the fair value hierarchy. The following inputs and assumptions were used for the periods presented:

 

   

Issuance Date

   

March 31, 2025

 

Share Price

  $ 0.23     $ 0.93  

Expected Life (in Years)

  $ 1.50     $ 1.75  

Annualized Volatility

    165.0 %     100.0 %

Risk-Free Annual Interest Rate

    4.4 %     3.9 %